Fundamental Valuation Report Apellis Pharmaceuticals(APLS:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$14.24 (USD) 27/02/2019 Weighted Valuation$37.26 (USD) Overall RatingUndervalued by 161.7% Valuation Models Analyst Consensus: $53.00 (USD) (in …

Apellis Pharmaceuticals (APLS:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Ares Management(ARES:NYS) Financial Services:Asset Management This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$23.60 (USD) 27/02/2019 Weighted Valuation$23.68 (USD) Overall RatingFairly valued to slightly Undervalued by 0.3% Valuation …

Ares Management (ARES:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Applied Optoelectronics(AAOI:NAS) Technology:Semiconductors This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$16.35 (USD) 27/02/2019 Weighted Valuation$13.00 (USD) Overall RatingOvervalued by 20.5% Valuation Models Analyst Consensus: $13.00 (USD) (in …

Applied Optoelectronics (AAOI:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Alcoa(AA:NYS) Basic Materials:Aluminum This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$30.98 (USD) 27/02/2019 Weighted Valuation$38.84 (USD) Overall RatingUndervalued by 25.4% Valuation Models Analyst Consensus: $40.00 (USD) (in …

Alcoa (AA:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Blue Apron Holdings(APRN:NYS) Consumer Cyclical:Specialty Retail This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$1.29 (USD) 26/02/2019 Weighted Valuation$1.78 (USD) Overall RatingUndervalued by 38.0% Valuation Models Analyst …

Blue Apron Holdings (APRN:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report American States Water(AWR:NYS) Utilities:Utilities-Regulated Water This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$70.13 (USD) 26/02/2019 Weighted Valuation$52.54 (USD) Overall RatingOvervalued by 25.1% Valuation Models Analyst Consensus: $48.00 …

American States Water (AWR:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Bristol-Myers Squibb(BMY:NYS) Healthcare:Drug Manufacturers-Major This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$50.16 (USD) 26/02/2019 Weighted Valuation$57.99 (USD) Overall RatingUndervalued by 15.6% Valuation Models Analyst Consensus: $58.00 (USD) …

Bristol-Myers Squibb (BMY:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Alimera Sciences(ALIM:NAS) Healthcare:Drug Manufacturers-Major This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$1.12 (USD) 26/02/2019 Weighted Valuation$2.33 (USD) Overall RatingUndervalued by 108.0% Valuation Models Analyst Consensus: $2.75 (USD) …

Alimera Sciences (ALIM:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report BWX Technologies(BWXT:NYS) Industrials:Aerospace & Defense This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$53.08 (USD) 26/02/2019 Weighted Valuation$53.66 (USD) Overall RatingFairly valued to slightly Undervalued by 1.1% Valuation …

BWX Technologies (BWXT:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Alder BioPharmaceuticals(ALDR:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$13.51 (USD) 26/02/2019 Weighted Valuation$15.36 (USD) Overall RatingUndervalued by 13.7% Valuation Models Analyst Consensus: $17.80 (USD) (in …

Alder BioPharmaceuticals (ALDR:NAS) Fundamental Valuation Report Read more »

Read More